Walgreens Boots Alliance, Inc. ( WBA) Stock. Should you Buy or Sell? $ 36.24
0.28 (0.77 %)
Walgreens Boots Alliance, Inc. AnalysisUpdated on 10-09-2022
|Volume Avg.||$6.77 M|
|Market Cap||$31.32 B|
|52 Week Range||$34.53 - $55.0|
Walgreens Boots Alliance, Inc. opened the day at $36.24 which is +'0.77 % on yesterday's close. Walgreens Boots Alliance, Inc. has a 52 week high of $55.0 and 52 week low of $34.53, which is a difference of $20.47. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $31.32 B and total net profit is $132509000000 which means the company is trading at 0.24 times profit to market capitalization. Theoretically, if you were to buy Walgreens Boots Alliance, Inc. for $31.32 B, it would take 15 years to get your money back. Walgreens Boots Alliance, Inc. are in the Pharmaceutical Retailers space which will have a sweet spot and industry standard for net profit multiples.
Walgreens Boots Alliance, Inc. Stock Forecast - Is Walgreens Boots Alliance, Inc. a Buy or Sell?
|DCF Score||Strong Buy|
|DE Score||Strong Buy|
|PE Score||Strong Buy|
|PB Score||Strong Buy|
|Overall Recommendation||Strong Buy|
Growth and Value
|Net Profit Margin||0.040|
Valuing Walgreens Boots Alliance, Inc.
|Price Book Value Ratio||1.193||Price To Book Ratio||1.193|
|Price To Sales Ratio||0.233||Price Earnings Ratio||5.821|
How liquid is Walgreens Boots Alliance, Inc.
|Debt Ratio||0.664||Debt Equity Ratio||2.346|
|Long Term Debt To Capitalization||0.551||Total Debt To Capitalization||0.587|
Latest news about Walgreens Boots Alliance, Inc.
U.S. pharmacy operators Walgreens Boots Alliance, Walmart Inc and Kroger Co on Tuesday faced off against the state of New Mexico in the latest trial over their alleged role in the U.S. opioid epidemic, following recent high-profile losses for pharmacies in other lawsuits.
Should investors be watching these dividend paying stocks this week?
Walgreens (WBA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Walgreens is looking cheap after declining by -33.53% YTD and pushing its price to FCF multiple to 8.86x. Walgreens has created value for shareholders despite its falling share price as its repurchased more than 20% of its shares outstanding since 2015.
Walgreens Boots Alliance, Inc. is the holding company that owns the pharmacy chains Walgreens and Boots, as well as some smaller pharma manufacturers and distributors. Trading at a one-year forward P/E of less than x6 and a dividend yield of greater than 5%, Walgreen Boots Alliance stock is just too attractive to ignore.
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.